Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian estimation of cost-effectiveness: an importance-sampling approach.

Daniel F Heitjan1, Huiling Li

  • 1Department of Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia 19104-6021, USA. dheitjan@cceb.upenn.edu

Health Economics
|January 23, 2004
PubMed
Summary

This study presents a Bayesian method for estimating treatment cost-effectiveness using clinical trial data. The approach models costs and binary effectiveness, offering a practical and flexible analysis for healthcare decision-making.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating clinical trial hazard functions.

Clinical trials (London, England)·2026
Same author

A Note on the Complementary Mixture Pareto II Distribution.

Communications in statistics: theory and methods·2026
Same author

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes.

Frontiers in cardiovascular medicine·2025
Same author

Toxic effects of chronic occupational mercury vapor exposure on female workers of childbearing age.

Journal of occupational medicine and toxicology (London, England)·2025
Same author

The effectiveness of sequential afatinib and furmonertinib in an advanced lung adenocarcinoma with rare compound EGFR mutation (L833V/H835L).

Anti-cancer drugs·2025
Same author

Effect of selenium on the dysfunction of rat salivary glands induced by 131I and expression of insulin-like growth factors and aquaporins.

Nuclear medicine communications·2025

Area of Science:

  • Health Economics
  • Biostatistics
  • Clinical Trial Analysis

Background:

  • Estimating the cost-effectiveness of new treatments is crucial for healthcare resource allocation.
  • Comparative clinical trials provide essential data for such evaluations.
  • Existing methods may lack flexibility in handling complex cost and effectiveness data.

Purpose of the Study:

  • To develop and illustrate a Bayesian statistical method for estimating treatment cost-effectiveness.
  • To quantify the cost-effectiveness using binary effectiveness outcomes and gamma-distributed costs.
  • To provide a practical and flexible framework for analyzing data from comparative clinical trials.

Main Methods:

  • Utilized a subjectivist Bayesian approach with prior probability distributions for model parameters.

Related Experiment Videos

  • Employed Bayes' theorem to update prior beliefs into posterior distributions.
  • Approximated posterior distributions using importance sampling, a simulation-based technique.
  • Modeled costs using separate gamma distributions for each treatment arm and effectiveness outcome combination.

    • Main Results:

    • Demonstrated the practical application of the Bayesian method in a heart disease clinical trial.
    • Successfully estimated cost-effectiveness based on one-year survival rates and resource usage data.
    • The method proved flexible in handling the specific data characteristics of the trial.

    Conclusions:

    • The proposed Bayesian method offers a robust and adaptable approach to cost-effectiveness analysis.
    • This framework facilitates informed decision-making in healthcare by integrating cost and effectiveness data.
    • The importance sampling technique provides a feasible way to approximate complex posterior distributions.